To unravel the mechanisms underlying the increased tumor promotion and progression observed in LRRK2 KI mice, we hypothesized that this mutation could enhance the susceptibility to DSS-induced colitis, thus promoting cancer pathogenesis. Here, LRRK2 is linked to cancer.